Position in PCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,088,952
+$1,830,277 QoQ
Shares Held
240,006
+27.4% QoQ
Ownership
0.602%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $1,596,028,663 across 49 Drug Manufacturers - Specialty & Generic names. PCRX ranks #26 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,926 | $282,045,178 | |
| 2 | LQDA |
Liquidia Corp
|
1,991,566 | $158,787,554 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,227,607 | $143,231,322 | |
| 4 | VTRS |
Viatris Inc
|
7,356,708 | $116,824,520 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
619,352 | $104,385,582 | |
| 6 | HLN |
Haleon plc
|
10,850,097 | $101,231,403 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
179,235 | $97,114,896 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,909,871 | $96,221,922 |
All Filings in PCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,088,952 | 240,006 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,258,675 | 188,437 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $4,782,804 | 184,807 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,110,157 | 159,494 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $7,077,983 | 296,150 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,484,108 | 260,930 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,584,789 | 137,197 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,644,189 | 242,139 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $15,992,616 | 558,987 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $17,514,437 | 599,399 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,358,952 | 455,215 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $10,028,921 | 326,888 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,388,945 | 184,401 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $9,224,772 | 226,042 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,875,164 | 178,067 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $10,328,059 | 194,173 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $12,932,105 | 221,820 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $14,809,969 | 194,051 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $11,462,022 | 190,494 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $11,226,824 | 200,479 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,044,850 | 182,018 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $13,659,978 | 194,892 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $8,853,624 | 147,955 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $9,280,723 | 154,370 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,468,551 | 161,398 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $6,107,755 | 182,158 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||